RecruitingNot ApplicableNCT07608926

Cardiovascular Prevention Supported by Digital Technology: Comparison With the Traditional Model


Sponsor

Maria Cecilia Hospital

Enrollment

144 participants

Start Date

May 28, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Cardiovascular diseases represent one of the leading causes of morbidity and mortality worldwide. Prevention in patients at cardiovascular risk is essential to reduce the incidence of cardiovascular events and slow the progression of risk. This study aims to evaluate the effectiveness and feasibility of a cardiovascular prevention pathway delivered remotely through a digital application, comparing it with a traditional in-person care pathway.


Eligibility

Min Age: 40 YearsMax Age: 75 Years

Inclusion Criteria8

  • Age between 40 and 75 years
  • hypertension
  • hyperglycaemia
  • type 2 diabetes not requiring insulin therapy
  • dyslipidaemia
  • active smoking
  • overweight/grade I obesity
  • Willingness to participate in follow-up visits over 24 months

Exclusion Criteria12

  • previous myocardial infarction
  • stroke
  • transient ischemic attack
  • coronary artery diseas
  • peripheral arterial occlusive disease
  • heart failure
  • Type 1 or type 2 diabetes mellitus on insulin therapy
  • Advanced chronic kidney disease (eGFR < 30 mL/min/1.73 m²)
  • Active cancer disease
  • Severe obesity
  • Inability to use digital tools
  • Pregnancy

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERRecommendations to the patient.

Recommendations to the patient


Locations(1)

Maria Cecilia Hospital

Cotignola, Ravenna, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07608926


Related Trials